newsfilter
← Latest News
Business Wire·

Alpha Cognition to Present Clinical Data at ASCP Annual Meeting

Alpha Cognition Inc. (NASDAQ:ACOG), a commercial-stage biopharmaceutical company developing therapies for neurodegenerative diseases, today announced it will present new clinical insights on cholinesterase inhibitors